← Back to All US Stocks

Anteris Technologies Global Corp. (AVR) Fundamental Analysis & AI Grade 2026

AVR Nasdaq Orthopedic, Prosthetic & Surgical Appliances & Supplies DE CIK: 0002011514
Updated This Month • Analysis: May 14, 2026 • SEC Data: 2026-03-31
Combined AI Grade
D
95% Confidence
STRONG AGREEMENT
D
95% Conf
D
95% Conf

📊 AVR Key Takeaways

Revenue: $494.0K
Net Margin: -4,660.7%
Free Cash Flow: $-28.8M
Current Ratio: 20.93x
Debt/Equity: 0.00x
EPS: $-0.28
AI Grade: D with 95% confidence
Anteris Technologies Global Corp. (AVR) receives a D fundamental grade with 95% confidence from our AI analysis based on SEC 10-K filings. With revenue of $494.0K, net profit margin of -4,660.7%, and return on equity (ROE) of -8.3%, Anteris Technologies Global Corp. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete AVR stock analysis for 2026.

Is Anteris Technologies Global Corp. (AVR) a Good Investment?

Claude

Anteris is a pre-revenue orthopedic device company burning $28.7M annually in operations with only $494K in quarterly revenue and no YoY growth, leaving approximately 1.1 years of cash runway. The company exhibits catastrophic operating margins of -4860% and no demonstrated path to profitability, and while the balance sheet remains strong, operational fundamentals are severely deteriorated.

ChatGPT

Anteris Technologies Global Corp.'s fundamentals are extremely weak: revenue is minimal at $1.91M while operating and net losses exceed $93M, producing deeply negative operating and net margins. Financial health is also strained, with negative equity, sub-1.0 liquidity ratios, and heavy cash burn that materially increases funding risk. Unless the company can materially improve commercialization and reduce burn, the current fundamentals indicate poor growth quality and elevated balance-sheet risk.

Anteris Technologies Global Corp. Key Strengths (AVR)

Claude
  • + Strong balance sheet with $278.4M stockholders' equity and minimal $18K long-term debt
  • + Adequate liquidity position with $31.7M cash reserves and exceptional 20.93x current ratio
  • + Positive cash position provides runway for continued operations and R&D investment
ChatGPT
  • + Cash of $12.58M provides some near-term operating flexibility
  • + Long-term debt is very low at $22.00K, limiting traditional leverage burden
  • + EPS loss improved year over year, suggesting some per-share loss moderation

AVR Stock Risks: Anteris Technologies Global Corp. Investment Risks

Claude
  • ! Minimal revenue generation at $494K quarterly with zero YoY growth indicates failed commercialization
  • ! Operating cash burn of $28.7M annually with only ~1.1 years of runway at current rate
  • ! Massive operating losses of $24M and net losses of $23M on negligible revenue demonstrate broken unit economics
  • ! Orthopedic device sector requires substantial R&D and regulatory costs with uncertain success probability
  • ! No visible path to profitability or positive operating cash flow based on current operational performance
ChatGPT
  • ! Negative stockholders' equity indicates a highly stressed balance sheet
  • ! Operating cash flow of -$77.80M and free cash flow of -$79.76M imply unsustainable cash burn relative to revenue
  • ! Current and quick ratios of 0.73x signal weak short-term liquidity and potential financing dependence

Key Metrics to Watch

Claude
  • * Quarterly revenue levels and YoY growth rate toward breakeven threshold
  • * Operating cash flow burn rate and months of remaining cash runway
  • * Regulatory approval status and product launch timeline for revenue-generating devices
  • * Gross margin achievement and operating leverage upon revenue inflection
  • * Working capital changes and stockholders' equity deterioration trajectory
ChatGPT
  • * Quarterly cash burn relative to cash balance
  • * Revenue growth and improvement in operating margin

Anteris Technologies Global Corp. (AVR) Financial Metrics & Key Ratios

Revenue
$494.0K
Net Income
$-23.0M
EPS (Diluted)
$-0.28
Free Cash Flow
$-28.8M
Total Assets
$294.7M
Cash Position
$31.7M

💡 AI Analyst Insight

Strong liquidity with a 20.93x current ratio provides a solid financial cushion.

AVR Profit Margin, ROE & Profitability Analysis

Gross Margin N/A
Operating Margin -4,859.7%
Net Margin -4,660.7%
ROE -8.3%
ROA -7.8%
FCF Margin -5,833.4%

AVR vs Healthcare Sector: How Anteris Technologies Global Corp. Compares

How Anteris Technologies Global Corp. compares to Healthcare sector averages

Net Margin
AVR -4,660.7%
vs
Sector Avg 12.0%
AVR Sector
ROE
AVR -8.3%
vs
Sector Avg 15.0%
AVR Sector
Current Ratio
AVR 20.9x
vs
Sector Avg 2.0x
AVR Sector
Debt/Equity
AVR 0.0x
vs
Sector Avg 0.6x
AVR Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Anteris Technologies Global Corp. Stock Overvalued? AVR Valuation Analysis 2026

Based on fundamental analysis, Anteris Technologies Global Corp. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
-8.3%
Sector avg: 15%
Net Profit Margin
-4,660.7%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.00x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Anteris Technologies Global Corp. Balance Sheet: AVR Debt, Cash & Liquidity

Current Ratio
20.93x
Quick Ratio
20.93x
Debt/Equity
0.00x
Debt/Assets
5.5%
Interest Coverage
-889.15x
Long-term Debt
$18.0K

AVR Revenue & Earnings Growth: 5-Year Financial Trend

AVR 5-year financial data: Year 2025: Revenue $2.7M, Net Income -$76.3M, EPS $-3.68.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Anteris Technologies Global Corp.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-3.68 indicates the company is currently unprofitable.

AVR Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-5,833.4%
Free cash flow / Revenue

AVR Quarterly Earnings & Performance

Quarterly financial performance data for Anteris Technologies Global Corp. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q1 2026 $494.0K -$21.9M $-0.28
Q3 2025 $429.0K -$21.9M $-0.62
Q2 2025 $618.0K -$18.7M $-0.58
Q1 2025 $556.0K -$16.4M $-0.61

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Anteris Technologies Global Corp. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$28.7M
Cash generated from operations
Capital Expenditures
$137.0K
Investment in assets
Dividends
None
No dividend program

AVR SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Anteris Technologies Global Corp. (CIK: 0002011514)

📋 Recent SEC Filings

Date Form Document Action
Jun 9, 2026 4 xslF345X06/form4.xml View →
Jun 9, 2026 4 xslF345X06/form4.xml View →
Jun 9, 2026 4 xslF345X06/form4.xml View →
Jun 4, 2026 4 xslF345X06/form4.xml View →
May 22, 2026 8-K ny20074564x2_8k.htm View →

Frequently Asked Questions about AVR

What is the AI rating for AVR?

Anteris Technologies Global Corp. (AVR) has a Combined AI Grade of D from Claude (D) and ChatGPT (D) with 95% combined confidence, based on fundamental analysis of SEC EDGAR filings.

What are AVR's key strengths?

Claude: Strong balance sheet with $278.4M stockholders' equity and minimal $18K long-term debt. Adequate liquidity position with $31.7M cash reserves and exceptional 20.93x current ratio. ChatGPT: Cash of $12.58M provides some near-term operating flexibility. Long-term debt is very low at $22.00K, limiting traditional leverage burden.

What are the risks of investing in AVR?

Claude: Minimal revenue generation at $494K quarterly with zero YoY growth indicates failed commercialization. Operating cash burn of $28.7M annually with only ~1.1 years of runway at current rate. ChatGPT: Negative stockholders' equity indicates a highly stressed balance sheet. Operating cash flow of -$77.80M and free cash flow of -$79.76M imply unsustainable cash burn relative to revenue.

What is AVR's revenue and growth?

Anteris Technologies Global Corp. reported revenue of $494.0K.

Does AVR pay dividends?

Anteris Technologies Global Corp. does not currently pay dividends.

Where can I find AVR SEC filings?

Official SEC filings for Anteris Technologies Global Corp. (CIK: 0002011514) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is AVR's EPS?

Anteris Technologies Global Corp. has a diluted EPS of $-0.28.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.

What is AVR's fundamental grade?

Based on our AI fundamental analysis in June 2026, Anteris Technologies Global Corp. has a D grade with 95% confidence. Review the strengths and risks sections above for full context. This is not investment advice.

Is AVR stock overvalued or undervalued?

Valuation metrics for AVR: ROE of -8.3% (sector avg: 15%), net margin of -4,660.7% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

What is AVR's AI grade for 2026?

Our dual AI analysis gives Anteris Technologies Global Corp. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is AVR's free cash flow?

Anteris Technologies Global Corp.'s operating cash flow is $-28.7M, with capital expenditures of $137.0K. FCF margin is -5,833.4%.

How does AVR compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin -4,660.7% (avg: 12%), ROE -8.3% (avg: 15%), current ratio 20.93 (avg: 2).

Top Rated Stocks
AAPL 92% MSFT 92% FAST 92% ANET 88% RDDT 88% KNSL 88% MGRE 88% FIZZ 88% AVGO 87% DECK 87%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: May 14, 2026 | Data as of: 2026-03-31 | Powered by Claude AI